Coronary revascularization and use of hemodynamic support in acute coronary syndromes

Iosif Xenogiannis, Peter Tajti, M. Nicholas Burke, Ivan Chavez, Mario Gössl, Michael Mooney, Anil Poulose, Paul Sorajja, Jay Traverse, Yale Wang, Emmanouil S. Brilakis

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


Cardiogenic shock develops in up to 10% of patients with acute myocardial infarction and continues to have high mortality. Early invasive treatment is the default therapeutic approach in these patients. On the basis of the results of the CULPRIT-SHOCK trial, culprit-only revascularization during the acute phase is preferred over multivessel revascularization. Routine use of intra-aortic balloon pump (IABP) is not recommended; however, the use of mechanical circulatory support has been increasing despite limited observational data to support its use. Several studies support multivessel revascularization in patients with uncomplicated ST-segment elevation acute myocardial infarction and simple nonculprit lesions to improve subsequent clinical outcomes.

Original languageEnglish (US)
Pages (from-to)165-170
Number of pages6
JournalHellenic Journal of Cardiology
Issue number3
StatePublished - May 1 2019
Externally publishedYes


  • Acute coronary syndromes
  • Cardiogenic shock
  • Multivessel coronary artery disease
  • Non-STEMI

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Coronary revascularization and use of hemodynamic support in acute coronary syndromes'. Together they form a unique fingerprint.

Cite this